Cephalexin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension
Condition:   Anti-Infective AgentsInterventions:   Drug: Cephalexin suspension (Optocef, BAYO5448 );   Drug: Cephalexin suspension (Keflex)Sponsors:   Bayer;   Bayer;   Corporación Bonima S.A. de C.V.Completed - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2010 Category: Research Source Type: clinical trials

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension
Condition:   Anti-Infective AgentsInterventions:   Drug: Cephalexin suspension (Optocef, BAYO5448 );   Drug: Cephalexin suspension (Keflex)Sponsors:   Bayer;   Corporación Bonima S.A. de C.V.Completed - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2010 Category: Research Source Type: clinical trials

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules
Condition:   Anti-Infective AgentsInterventions:   Drug: Cephalexin capsules (Optocef, BAYO5448 );   Drug: Cephalexin capsules (Keflex)Sponsors:   Bayer;   Corporación Bonima S.A. de C.V.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2010 Category: Research Source Type: clinical trials

Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
Condition:   CellulitisInterventions:   Drug: IV cefazolin plus oral probenecid and placebo cephalexin;   Drug: Oral cephalexin and saline IV plus probenecid placeboSponsors:   Kelowna General Hospital;   Canadian Society of Hospital Pharmacists;   Capital Health, Canada;   Interior Health Authority, CanadaCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2009 Category: Research Source Type: clinical trials

Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"
Condition:   Staphylococcal InfectionInterventions:   Drug: Cephalexin;   Drug: Clindamycin;   Other: Placebo;   Drug: Trimethoprim-sulfamethoxazoleSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2008 Category: Research Source Type: clinical trials